Implications of cancer evolution for drug development.

View/ Open
Publication Date
2017-07Author
Turajlic, S
Swanton, C
Type
Journal Article
Metadata
Show full item recordCollections
Version of record
Subject
Humans
Neoplasms
Antineoplastic Agents
Evolution, Molecular
Drug Design
Drug Resistance, Neoplasm
Language
eng
License start date
2017-07
Citation
Nature reviews. Drug discovery, 2017, 16 (7), pp. 441 - 442